REVVITY, INC Proceeds from Long-term Lines of Credit
REVVITY, INC (RVTY) reported Proceeds from Long-term Lines of Credit of $0 for the 12-month period ending 2024-12-29, per its 10-K filed 2025-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2025-02-25
- REVVITY, INC proceeds from long-term lines of credit for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC proceeds from long-term lines of credit for the quarter ending 2023-10-01 was $0.00.
- REVVITY, INC proceeds from long-term lines of credit for the quarter ending 2023-07-02 was $0.00.
- REVVITY, INC proceeds from long-term lines of credit for the quarter ending 2023-04-02 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC proceeds from long-term lines of credit for fiscal 2024 was $0.00.
- REVVITY, INC proceeds from long-term lines of credit for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2023.
- REVVITY, INC proceeds from long-term lines of credit for fiscal 2023 was $240.00M, a 87.37% decline from fiscal 2022.
- REVVITY, INC proceeds from long-term lines of credit for fiscal 2022 was $1.90B, a 165.89% increase from fiscal 2021.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month | Proceeds from Long-term Lines of Credit 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-29 | $0.00 10-K · filed 2025-02-25 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | |
| 2023-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $20.00M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $20.00M derived: sum of 3 quarters · filed 2025-02-25 | $20.00M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-04-02 | $0.00 10-Q · filed 2023-05-12 | $20.00M derived: sum of 2 quarters · filed 2025-02-25 | $20.00M derived: sum of 3 quarters · filed 2025-02-25 | $20.00M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-01-01 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $20.00M derived: sum of 2 quarters · filed 2025-02-25 | $20.00M derived: sum of 3 quarters · filed 2025-02-25 | $240.00M 10-K · filed 2025-02-25 | |
| 2022-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $220.00M 10-Q · filed 2023-11-07 | $976.00M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $220.00M 10-Q · filed 2023-08-09 | $976.00M derived: sum of 3 quarters · filed 2024-02-27 | $1.39B derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-04-03 | $220.00M 10-Q · filed 2023-05-12 | $976.00M derived: sum of 2 quarters · filed 2024-02-27 | $1.39B derived: sum of 3 quarters · filed 2024-02-27 | $1.54B derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-01-02 | $756.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.17B derived: sum of 2 quarters · filed 2024-02-27 | $1.32B derived: sum of 3 quarters · filed 2024-02-27 | $1.90B 10-K · filed 2024-02-27 | $1.40B 10-K · filed 2022-03-03 |
| 2021-10-03 | $415.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $560.28M derived: sum of 2 quarters · filed 2022-11-14 | $1.14B 10-Q · filed 2022-11-14 | $1.60B derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-07-04 | $145.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $729.00M 10-Q · filed 2022-08-09 | $1.19B derived: sum of 3 quarters · filed 2023-03-01 | $1.26B derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-04-04 | $584.00M 10-Q · filed 2022-05-10 | $1.04B derived: sum of 2 quarters · filed 2023-03-01 | $1.11B derived: sum of 3 quarters · filed 2023-03-01 | $1.17B derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-01-03 | $457.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $526.70M derived: sum of 2 quarters · filed 2023-03-01 | $589.70M derived: sum of 3 quarters · filed 2023-03-01 | $714.70M 10-K · filed 2023-03-01 | |
| 2020-10-04 | $69.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $132.00M derived: sum of 2 quarters · filed 2021-11-09 | $257.00M 10-Q · filed 2021-11-09 | $822.00M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-07-05 | $63.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $188.00M 10-Q · filed 2021-08-10 | $753.00M derived: sum of 3 quarters · filed 2022-03-03 | $937.87M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-04-05 | $125.00M 10-Q · filed 2021-05-11 | $690.00M derived: sum of 2 quarters · filed 2022-03-03 | $874.87M derived: sum of 3 quarters · filed 2022-03-03 | $1.55B derived: sum of 4 quarters · filed 2022-03-03 | |
| 2019-12-29 | $565.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $749.87M derived: sum of 2 quarters · filed 2022-03-03 | $1.42B derived: sum of 3 quarters · filed 2022-03-03 | $1.60B 10-K · filed 2022-03-03 | |
| 2019-09-29 | $184.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $855.42M derived: sum of 2 quarters · filed 2020-11-10 | $1.03B 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $670.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $849.55M 10-Q · filed 2020-08-11 | |||
| 2019-03-31 | $179.00M 10-Q · filed 2020-05-12 | ||||
| 2018-12-30 | $857.00M 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |